A clinically useful risk‐score for chronic kidney disease in HIV infection
Amanda Mocroft(University of Copenhagen), Lene Ryom(University of Copenhagen), Peter Reiß(Institut polytechnique de Grenoble), Margaret Johnson(The Royal Free Hospital), Ole Kirk(University of Copenhagen), Matthew Law(UNSW Sydney), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Olivier Moranne(US Forest Service), Jacquie Heuhaus(University of Minnesota), Debbie Wentworth(University of Minnesota), Christophe Fux(Kantonsspital Aarau), Phillipe Morlat(Université de Bordeaux), Michael J. Ross(Icahn School of Medicine at Mount Sinai), Colette Smith(MRC Clinical Trials Unit at UCL)
Cited by 12
Related Papers
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Prospects of Nanoscience with Nanocrystals
|ACS Nano|2015|1.2k
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k